William Wood
Stock Analyst at B. Riley Securities
(0.56)
# 4,360
Out of 5,144 analysts
66
Total ratings
35.1%
Success rate
-5.6%
Average return
Main Sectors:
Stocks Rated by William Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALT Altimmune | Maintained: Buy | $13 → $11 | $1.61 | +583.23% | 2 | Nov 16, 2026 | |
| ACOG Alpha Cognition | Maintained: Buy | $21 | $8.56 | +145.33% | 2 | Nov 13, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $7 | $1.14 | +514.04% | 3 | Nov 13, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $85 | $27.58 | +208.19% | 4 | Oct 29, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $11 → $8 | $1.66 | +383.38% | 11 | Sep 11, 2026 | |
| MBOT Microbot Medical | Initiated Coverage: Buy | $4 | $1.03 | +288.35% | 1 | Sep 11, 2026 | |
| IMUX Immunic | Reiterated: Buy | $27 | $7.79 | +246.60% | 11 | Sep 2, 2026 | |
| TGTX TG Therapeutics | Reiterated: Buy | $86 | $64.56 | +33.21% | 3 | Sep 2, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $6 | $0.7622 | +687.19% | 1 | Aug 31, 2026 | |
| AGMB AgomAb Therapeutics NV | Initiated Coverage: Buy | $34 | $6.36 | +434.59% | 1 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $13.62 | +127.61% | 1 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.32 | +354.55% | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $1.52 | +360.53% | 3 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $560 → $670 | $425.21 | +57.57% | 3 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.40 | +257.14% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.6763 | +343.59% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $2.12 | n/a | 7 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $8.49 | n/a | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.69 | n/a | 4 | May 2, 2024 |
Altimmune
Nov 16, 2026
Maintained: Buy
Price Target: $13 → $11
Current: $1.61
Upside: +583.23%
Alpha Cognition
Nov 13, 2026
Maintained: Buy
Price Target: $21
Current: $8.56
Upside: +145.33%
Palisade Bio
Nov 13, 2026
Reiterated: Buy
Price Target: $7
Current: $1.14
Upside: +514.04%
Viking Therapeutics
Oct 29, 2026
Reiterated: Buy
Price Target: $85
Current: $27.58
Upside: +208.19%
LifeMD
Sep 11, 2026
Reiterated: Buy
Price Target: $11 → $8
Current: $1.66
Upside: +383.38%
Microbot Medical
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $1.03
Upside: +288.35%
Immunic
Sep 2, 2026
Reiterated: Buy
Price Target: $27
Current: $7.79
Upside: +246.60%
TG Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $86
Current: $64.56
Upside: +33.21%
iBio, Inc.
Aug 31, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $0.7622
Upside: +687.19%
AgomAb Therapeutics NV
Jul 23, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $6.36
Upside: +434.59%
Jul 17, 2026
Reiterated: Buy
Price Target: $31
Current: $13.62
Upside: +127.61%
Jun 2, 2026
Reiterated: Buy
Price Target: $6
Current: $1.32
Upside: +354.55%
May 15, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $1.52
Upside: +360.53%
Dec 11, 2025
Reiterated: Buy
Price Target: $560 → $670
Current: $425.21
Upside: +57.57%
Dec 8, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.40
Upside: +257.14%
Nov 21, 2025
Reiterated: Buy
Price Target: $3
Current: $0.6763
Upside: +343.59%
Feb 11, 2025
Reiterated: Buy
Price Target: $50
Current: $2.12
Upside: n/a
May 8, 2024
Reiterated: Buy
Price Target: $10
Current: $8.49
Upside: n/a
May 2, 2024
Reiterated: Buy
Price Target: $4
Current: $3.69
Upside: n/a